[ET Net News Agency, 30 September 2021] Morgan Stanley lowered its target price for Bud
APAC (01876) to HK$29 from HK$32 and maintained its "overweight" rating.
The research house said to factor in the near-term impact of COVID-19, it lowers the
revenue forecast 3% for 2021 and ~1% for 2022 and 2023 with a lower base. (RC)